Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes
Author(s) -
Melanie CreeGreen,
Bryan C. Bergman,
Eda Cengiz,
Larry A. Fox,
Tamara S. Han,
Kellee M. Miller,
Brandon M. Nathan,
Laura Pyle,
Darcy E. Kahn,
Michael Tansey,
Eileen Tichy,
Eva Tsalikian,
Ingrid Libman,
Kristen J. Nadeau
Publication year - 2019
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2019-00129
Subject(s) - metformin , type 2 diabetes , insulin sensitivity , medicine , peripheral , endocrinology , sensitivity (control systems) , diabetes mellitus , insulin , insulin resistance , engineering , electronic engineering
Type 1 diabetes in adolescence is characterized by insulin deficiency and insulin resistance (IR), both thought to increase cardiovascular disease risk. We previously demonstrated that adolescents with type 1 diabetes have adipose, hepatic, and muscle IR, and that metformin lowers daily insulin dose, suggesting improved IR. However, whether metformin improves IR in muscle, hepatic, or adipose tissues in type 1 diabetes was unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom